Investing.com -- Quest Diagnostics (NYSE: NYSE: DGX ), a prominent player in diagnostic information services, announced today ...

"We do not expect any changes in Bank of Japan (BoJ) policy at the upcoming monetary policy meeting on 18-19 March," UBS ...

In conclusion, Jensen Huang’s GTC 2024 keynote speech has delivered a vision of AI’s transformative potential. Through his ...

The controversy arose after President Trump took to social media on Tuesday to demand the impeachment of U.S. District Judge ...

"We now see the stock running out of runway for further near-term upside relative to other stocks in our coverage universe," ...

Max, Duolingo’s premium tier priced at approximately twice the rate of Super, contributed 8 percentage points to 2024 ...

Google (NASDAQ:GOOGL)’s Gemini, a tool known for assisting in brainstorming, research, and content generation, has introduced ...

Investing.com -- Palantir Technologies continues to receive strong customer praise for its AI Platform (AIP), but insider ...

Adobe (NASDAQ: ADBE), known for popular consumer applications like Photoshop, has announced the rollout of artificial ...

EMERYVILLE, Calif. - OmniAb, Inc. (NASDAQ: OABI) reported a significant revenue increase for the fourth quarter of 2024, driving its shares up 6.6% in after-hours trading. The antibody discovery ...

The company posted revenue of $0.7 million for Q4 2024, falling short of the $1.8 million consensus estimate. Adjusted earnings per share came in at -$0.25, $0.03 worse than analysts expected.

Shares of Gilead Sciences (NASDAQ: NASDAQ:GILD) fell 3.4% following a recent Wall Street Journal report indicating that the Health and Human Services Department is considering significant reductions ...